🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. EXPAREL and bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain Management

    approved small molecule terminated

    1 trial

  2. Enoxaparin 40 mg q12h

    United Therapeutics Europe Ltd

    Traumatic Injury

    approved small molecule completed

    1 trial

  3. Epoetin Alfa

    United Therapeutics Europe Ltd

    Exercise-Induced Anemia

    approved small molecule completed

    1 trial

  4. Etanercept

    Pfizer

    Moderate to Severe Psoriasis

    approved small molecule completed

    1 trial

  5. Exparel

    Pacira Ireland Limited

    Analgesia, Postoperative

    approved small molecule completed

    1 trial

  6. Exparel 266 MG Per 20 ML Injection

    Pacira Ireland Limited

    Post Operative Pain

    approved small molecule active

    1 trial

  7. Experimental continuous peripheral nerve blocks

    United Therapeutics Europe Ltd

    Lower Extremity Surgical Amputation

    approved small molecule active

    1 trial

  8. Experimental: Hyperslim

    Vera Therapeutics

    Venous Thromboembolism (VTE)

    approved other active

    1 trial

  9. Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  10. Eylea 114.3 mg/ml solution for injection

    Bayer AG

    Neovascular age-related macular degeneration (nAMD), Diabetic macular edema (DME)

    approved small molecule active

    1 trial

  11. FTC-TDF PrEP

    United Therapeutics Europe Ltd

    HIV Infection

    approved small molecule completed

    1 trial

  12. Fenfluramine

    United Therapeutics Europe Ltd

    Cognitive Function

    approved small molecule completed

    1 trial

  13. Fenofibrate 145 mg

    United Therapeutics Europe Ltd

    Diabetic Retinopathy

    approved small molecule completed

    1 trial

  14. Feraccru 30 mg hard capsules

    Lacuna Pharma Pty Ltd

    iron deficient

    approved small molecule active

    1 trial

  15. Ferric carboxymaltose

    United Therapeutics Europe Ltd

    Anemia

    approved small molecule completed

    1 trial

  16. Filgotinib

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    approved small molecule active

    8 trials

  17. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  18. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  19. Gabapentin

    United Therapeutics Europe Ltd

    Peripheral Nerve Disorder Associated With Repair of Hernia

    approved small molecule active

    1 trial

  20. Gadoterate meglumine

    Guerbet

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  21. Glycopyrronium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Nausea and Vomiting

    approved small molecule active

    1 trial

  22. Glycopyrronium in Combination With Tropisetron

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    approved small molecule completed

    1 trial

  23. Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule terminated

    1 trial

  24. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources